Skip to content

CONMED CNMD Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$0-100%
Stryker logo
StrykerSYK
$0-100%
OSI Systems logo
OSI SystemsOSIS
$82K+156%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$744M+6.3%
Medtronic logo
MedtronicMDT
$1.75B
Merit Medical Systems logo
Merit Medical SystemsMMSI
$718.7M+1,577%

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's debt issuance proceeds?
CONMED (CNMD) reported debt issuance proceeds of $180M in Q1 2026.
How has CONMED's debt issuance proceeds changed year-over-year?
CONMED's debt issuance proceeds increased by 8.4% year-over-year, from $166M to $180M.
What is the long-term trend for CONMED's debt issuance proceeds?
Over 4 years (2021 to 2025), CONMED's debt issuance proceeds has grown at a 20.8% compound annual growth rate (CAGR), from $326.75M to $695.43M.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.